CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its third quarter ended September 30, 2008. Revenues for the third quarter were $362 million, an increase of 15 percent over the $315 million reported for the third quarter of 2007.
